IPILIMUMAB N01

Clinical trials for IPILIMUMAB N01 explained in plain language.

Never miss a new study

Get alerted when new IPILIMUMAB N01 trials appear

Sign up with your email to follow new studies for IPILIMUMAB N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cocktail aims to outsmart deadly colorectal cancer

Disease control Recruiting now

This study tests a combination of four drugs (sintilimab, ipilimumab, cetuximab, and dabrafenib) in people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable. These cancers are hard to treat and don't respond well to sta…

Matched conditions: IPILIMUMAB N01

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 18, 2026 11:48 UTC

IPILIMUMAB N01

Get alerted when new IPILIMUMAB N01 trials appear

New cocktail aims to outsmart deadly colorectal cancer